ACADIA Pharmaceuticals (ACAD) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is the Options Market Predicting a Spike in ACADIA Pharmaceuticals (ACAD) Stock?
Zacks Feb 13 07:35 ET
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
BusinesswireFeb 12 16:05 ET
10 Health Care Stocks With Whale Alerts In Today's Session
BenzingaFeb 12 12:35 ET
Deutsche Bank Downgrades ACADIA Pharmaceuticals(ACAD.US) to Hold Rating, Cuts Target Price to $22
Moomoo NewsFeb 12 06:31 ET · Ratings
ACADIA Pharmaceuticals Analyst Ratings
BenzingaFeb 11 12:54 ET · Ratings
Express News | ACADIA Pharmaceuticals Inc : Deutsche Bank Initiates Coverage With Hold Rating; Price Target $22
ReutersFeb 11 03:01 ET

Comments

Jaguar8

Jan 14 08:06

NEWS

$ACADIA Pharmaceuticals (ACAD.US)$
Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome
6 minutes ago, 6:00 AM PST
Via BusinessWire
ACAD
Share
-- Filing marks company's first Marketing Authorization Application in Europe
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that the company has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for tr...

2

Trytosaveabit

Dec 11, 2024 15:06

News

$ACADIA Pharmaceuticals (ACAD.US)$ Reuters· 1 min ago
ACADIA Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million

1

Jaguar8

Nov 26, 2024 23:04

My Wednesday Watchlist. Trade the chart. Do not be impulsive. 11 stocks on watchlist today ran.

$HWH International (HWH.US)$ 13D 88.9%. China stock. Low float. SI 214%✅
$Infobird Software (IFBD.US)$ Completed $40M acquisition. China stock. Low float. 0 shares LTB✅
$Ocean Power Technologies (OPTT.US)$ Form 4 insider buying. 0 shares LTB✅
$T Stamp (IDAI.US)$ Ran today. Up after hours. Possible catalyst. Low float. 0 shares LTB✅
$Syra Health (SYRA.US)$ Recent Form 4s multiple insider loading. Low fl...

38

20

3

Jaguar8

Nov 26, 2024 15:13

NEWS

$ACADIA Pharmaceuticals (ACAD.US)$
Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711
Acadia Pharmaceuticals (NASDAQ: ACAD) has secured an exclusive worldwide license agreement with Saniona for SAN711, a first-in-class GABAA-α3 positive allosteric modulator.
The company plans to develop SAN711 for essential tremor treatment, with Phase 2 studies expected to begin in 2026. Under the agreement, Saniona will receive a $28 million upfront payment plus potential ...

Trytosaveabit

Nov 26, 2024 15:08

News

$ACADIA Pharmaceuticals (ACAD.US)$ Reuters· 1 min ago
ACADIA Pharmaceuticals Inc - Saniona to Receive $28 Million Upfront Plus up to $582 Million in Milestones with exclusive licensing agreement with Saniona for San711

1

ACAD ACADIA Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Trending Stocks